McDonald, Kellen M.
Son, Jake J.
Schantell, Mikki
Petro, Nathan M.
Glesinger, Ryan
Okelberry, Hannah J.
John, Jason A.
Horne, Lucy K.
May-Weeks, Pamela E.
Case, Adam J.
Zimmerman, Matthew C.
Spooner, Rachel K.
Wilson, Tony W.
Funding for this research was provided by:
National Institute on Drug Abuse (F31-DA063403)
National Institute on Drug Abuse (F31-DA056296)
National Institute on Drug Abuse (R01-DA056223)
National Institute of Neurological Disorders and Stroke (R01-NS141729)
NIH Office of the Director (S10-OD028751)
National Institute of General Medical Sciences (P20-GM144641)
Article History
Received: 26 August 2025
Accepted: 7 January 2026
First Online: 16 January 2026
Declarations
:
: The Institutional Review Board (IRB) at the University of Nebraska Medical Center reviewed and approved the study protocol. Written informed consent was obtained from each participant after a full description of the study, which was conducted in accordance with the Declaration of Helsinki.
: Not applicable.
: The authors declare no competing interests.